Synergy Life Science Partner
19
21M
8
2
0.58
6
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Portola Valley.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Manufacturing. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Barosense, Oraya Therapeutics, NeuroTronik
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2009. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2018. Comparing to the other companies, this Synergy Life Science Partner performs on 1 percentage points less the average number of lead investments. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies.
The fund was created by John Onopchenko, Richard Stack, William Starling. The overall number of key employees were 2.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Synergy Life Science Partner, startups are often financed by U.S. Venture Partners (USVP), Mohr Davidow Ventures, Medtronic. The meaningful sponsors for the fund in investment in the same round are U.S. Venture Partners (USVP), Mohr Davidow Ventures, Medtronic. In the next rounds fund is usually obtained by Mohr Davidow Ventures, U.S. Venture Partners (USVP), Medtronic.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 2
- Exits
- 6
- Follow on index
- 0.58
- Investments by industry
- Medical Device (19)
- Health Care (18)
- Biotechnology (9)
- mHealth (6)
- Health Diagnostics (6) Show 6 more
- Investments by region
-
- United States (19)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 13M
- Group Appearance index
- 0.95
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.20
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| iRhythm Technologies | 18 May 2009 | Health Care, Health Diagnostics, Medical Device, mHealth, Wearables | Early Stage Venture | 6M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.